This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Universitéde Liége. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Gabriel Mazzucchelli: Innovator in Osteoarthritis Biomarkers
Introduction
Gabriel Mazzucchelli is a notable inventor based in Liège, Belgium. He has made significant contributions to the field of medical diagnostics, particularly concerning osteoarthritis. His innovative work focuses on the use of osteomodulin as a biomarker for diagnosing and prognosing osteoarthritis and subchondral bone sclerosis.
Latest Patents
Mazzucchelli holds a patent for "Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof." This invention involves the use of osteomodulin (OMD) protein or its fragments to assess the prognosis and diagnosis of osteoarthritis in mammals, especially humans. The method includes measuring OMD levels in body fluid samples, such as serum, and determining the onset of osteoarthritis based on these levels.
Career Highlights
Gabriel Mazzucchelli is affiliated with the Université de Liège, where he conducts research and develops innovative solutions in the medical field. His work has the potential to improve the diagnosis and management of osteoarthritis, a condition affecting millions worldwide.
Collaborations
Mazzucchelli has collaborated with esteemed colleagues, including Yves Henrotin and Christelle Sanchez, to advance research in osteoarthritis and related fields.
Conclusion
Gabriel Mazzucchelli's contributions to the understanding and diagnosis of osteoarthritis through his innovative patent highlight his role as a key figure in medical research. His work continues to pave the way for advancements in the field of diagnostics.